Meningococcal Vaccines Market - Forecast(2024 - 2030)

Report Code: HCR 1447 Report Format: PDF + Excel

Meningococcal Vaccines Market Overview

Meningococcal Vaccines Market size is expected to reach $4.2 billion by 2026, growing at a CAGR of 10.8% during the forecast period 2021-2026. Meningococcal vaccines are polysaccharide vaccines that are used to prevent diseases caused by meningococcus, which is a Gram-negative bacterium that can cause meningitis and other forms of meningococcal disease such as meningococcemia. The meningococcal disease results in infection of the lining of the brain and spinal cord and also has the potential to cause large epidemics. This disease is generally transmitted through direct contact with droplets of throat secretions from patients. Increase in the demand for combination vaccines and conjugate vaccines, growing government initiatives to replace the current meningitis vaccines with new vaccines to combat rising deaths, and rise in the adoption in developing countries in their national immunization programs are the factors that are set to drive the growth of the Meningococcal Vaccines Market for the period 2021-2026.

Meningococcal Vaccines Market Report Coverage

The report: “Meningococcal Vaccines Market Forecast (2021-2026)”, by Industry ARC, covers an in-depth analysis of the following segments of the Meningococcal Vaccines Market.
By Type: Bivalent, Quadrivalent, and Others.
By Brand: Bexsero, Trumenba, Menactra, Menveo, and Others.
By Age Group: Infants, Adolescents, and Adults.
By Geography: North America (U.S., Canada, and Mexico), Europe (Germany, UK, France, Italy, Spain, Russia, and Rest of Europe), Asia-Pacific (China, India, Japan, South Korea, Australia & New Zealand, and Rest of Asia-Pacific), South America (Brazil, Argentina, and Rest of South America) and Rest of World (Middle East and Africa).

Key Takeaways

  • North America Meningococcal Vaccines Market accounted for the highest revenue share in 2020 and it is poised to dominate over the period 2021-2026 owing to the growing approval of new vaccines to protect people against meningococcal meningitis.
  • The increasing demand for meningococcal conjugate vaccines for treating the infant population is driving the segment of Infants.
  • The lack of awareness of the harmful effect of meningitis in toddlers and young children is one of the major factors that is said to reduce the growth of the Meningococcal Vaccines Market.
  • Detailed analysis on the Strength, Weakness, and Opportunities of the prominent players operating in the market will be provided in the Meningococcal Vaccines Market report.

Meningococcal Vaccines Market Segment Analysis-By Type

The Meningococcal Vaccines Market based on the Type can be further segmented into Bivalent, Quadrivalent, and Others. The Quadrivalent segment held the largest share in 2020 and is also estimated to be the fastest-growing segment with a CAGR of 11.6% over the period 2021-2026. This growth is owing to the growing usage from brands such as Menactra, Menveo, and Nimenrix. The quadrivalent Conjugate Vaccines are increasingly being used for the active immunization of individuals. The increasing approval of new vaccines to protect people against meningococcal meningitis is driving the growth of the Meningococcal Vaccines Market. The Bivalent segment held the second-largest share in 2020 owing to the factors such as growing demand for bivalent meningococcal vaccine for adolescents and young adults and increase in the research and development activities by the key players.

Meningococcal Vaccines Market Segment Analysis-By Age Group

The Meningococcal Vaccines Market based on the Age Group can be further segmented into Infants, Adolescents, and Adults. The Infants segment held the largest share in 2020 and is also estimated to be the fastest-growing segment with a CAGR of 11.5% over the period 2021-2026. This growth is owing to the increasing demand for meningococcal conjugate vaccines for treating the infant population. The growing government initiatives to replace the current polysaccharide vaccines with new vaccines to combat rising deaths owing to meningitis is driving the growth of the Meningococcal Vaccines Market. The Adolescent segment held the second-largest share in 2020 owing to the factors such as growing demand for meningococcal combination vaccines for treating the adolescent population and increase in the prevalence of meningococcal diseases in developing countries.

Meningococcal Vaccines Market Size, By Age Group 2020-2026 (USD Million)



Meningococcal Vaccines Market Segment Analysis-By Geography

North America held the largest share with 29% of the overall market in 2020. The growth in this segment is owing to the factors such as increase in the government initiatives to develop new vaccines to combat rising deaths and growing approval of new vaccines to protect people against meningococcal meningitis. The rising demand for meningococcal combination vaccines for adolescents is driving the growth of the Meningococcal Vaccines Market. Asia Pacific is estimated to be the fastest growing segment over the period 2021-2026. The growth in this segment is owing to the factors such as increase in the research and development activities by the key players to develop polysaccharide vaccines, rise in the launches of conjugate vaccines in the region, and increase in the adoption of immunization programs.

Meningococcal Vaccines Market Drivers

Rise in the Demand for Meningococcal Conjugate Vaccines.

There is a rapid increase in the demand for meningococcal conjugate vaccines owing to its capability of protecting against four types (serogroups A, C, W, and Y) of Neisseria meningitidis bacteria. It also provides the ability to induce greater antibody persistence, avidity, immunologic memory, and herd immunity, which is driving the growth of the Meningococcal Vaccines Market.

Increase in the Focus on Developing New Vaccines.

The key players are focusing on developing polysaccharide vaccines that do not depend on very narrow range temperatures for storage. The manufacturers are also aimed at developing vaccines that provide an effective, long-term, and affordable solution to epidemics caused owing to meningococcal disease, which is driving the growth of the Meningococcal Vaccines Market.

Meningococcal Vaccines Market Challenges

Lack of Awareness of the Harmful Effect of Meningitis in Toddlers and Young Children.

Meningococcal vaccines are increasingly being adopted in several countries in their national immunization programs and surge in meningococcal outbreaks in several countries have further propelled the demand for meningococcal vaccines. However, lack of awareness of the harmful effect of meningitis in toddlers and young children is one of the major factors that is estimated to reduce the growth of the Meningococcal Vaccines Market.

Meningococcal Vaccines Market Landscape

Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the Meningococcal Vaccines Market. Key companies of this market are GlaxoSmithKline PLC, Pfizer Inc, Walvax Biotechnology Co Ltd, Bio-Med Pvt Ltd, Bio-Manguinhos, Chongqing Zhifei Biological Products Co Ltd, Incepta Pharmaceuticals Ltd, Serum Institute of India Pvt. Ltd, Sanofi S.A, Hualan Biological Engineering, Inc among others.

Acquisitions/Product Launches:

  • In July 2020, Pfizer Inc has entered into partnership with CanSino Biologics to promote meningitis vaccine candidate in China to offer protection against the severe infectious disease caused by Meningococcus bacteria.
  • In February 2020, GlaxoSmithKline PLC has launched the Menveo vaccine in India for protection against meningococcal disease for use in infants as young as 2 months of age. It is used to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y, and W-135.
  • In February 2020, Serum Institute of India (SII) has announced the launch of the world's most affordable pneumococcal conjugate vaccines (PCV) that provides protection against 10 variants of pneumococcus bacteria that causes pneumonia, meningitis, and blood infections in children.

Related Reports

Report Code: HCR 0711

Report Code: HCR 1348

For more Lifesciences and Healthcare Market reports, Please click here
1. Meningococcal Vaccines Market - Overview
    1.1 Definitions and Scope
2. Meningococcal Vaccines Market - Executive Summary
    2.1 Market Revenue and Key Trends by Company
    2.2 Key trends by Type
    2.3 Key trends by Age Group
    2.4 Key trends by Geography
3. Meningococcal Vaccines Market – Comparative Analysis
    3.1 Product Benchmarking – Key Companies
    3.2 Financial Analysis – Key Companies
    3.3 Market Value Split by Key Companies
    3.4 Patent Analysis – Key Companies
    3.5 Pricing Analysis
4. Meningococcal Vaccines Market - Startup Companies Scenario Premium
    4.1 Key Startup Company Analysis by
        4.1.1 Investment
        4.1.2 Revenue
        4.1.3 Venture Capital and Funding Scenario
5.  Meningococcal Vaccines Market – Industry Market Entry Scenario Premium Premium
    5.1 Regulatory Framework Overview
    5.2 New Business and Ease of Doing business index
    5.3 Case Studies of Successful Ventures
6. Meningococcal Vaccines Market Forces
    6.1 Market Drivers
    6.2 Market Constraints/Challenges
    6.3 Porters five force model
        6.3.1 Bargaining power of suppliers
        6.3.2 Bargaining powers of customers
        6.3.3 Threat of new entrants
        6.3.4 Rivalry among existing players
        6.3.5 Threat of substitutes
7. Meningococcal Vaccines Market – Strategic Analysis
    7.1 Value Chain Analysis
    7.2 Opportunities Analysis
    7.3 Market Life Cycle
8. Meningococcal Vaccines Market – By Type (Market Size –$Million/$Billion)
    8.1 Bivalent
    8.2 Quadrivalent
    8.3 Others
9. Meningococcal Vaccines Market – By Brand (Market Size –$Million/$Billion)
    9.1 Bexsero
    9.2 Trumenba
    9.3 Menactra
    9.4 Menveo
    9.5 Others
10. Meningococcal Vaccines Market – By Age Group (Market Size –$Million/$Billion)
    10.1 Infants
    10.2 Adolescents
    10.3 Adults
11. Meningococcal Vaccines Market - By Geography (Market Size –$Million/$Billion)
    11.1 North America
        11.1.1 U.S.
        11.1.2 Mexico
        11.1.3 Canada
    11.2 Europe
        11.2.1 U.K.
        11.2.2 France
        11.2.3 Germany
        11.2.4 Italy
        11.2.5 Spain
        11.2.6 Russia
        11.2.7 Rest of Europe
    11.3 Asia Pacific
        11.3.1 China
        11.3.2 India
        11.3.3 Japan
        11.3.4 South Korea
        11.3.5 Australia & New Zealand
        11.3.6 Rest of APAC
    11.4 South America
        11.4.1 Brazil
        11.4.2 Argentina
        11.4.3 Rest of South America
    11.5 Rest of the World
        11.5.1 Middle East
        11.5.2 Africa
12. Meningococcal Vaccines Market - Entropy
13. Meningococcal Vaccines Market – Industry/Segment Competition Landscape Premium
    13.1 Market Share Analysis
        13.1.1 Market Share at Global Level– Key Companies
        13.1.2 Market Share by Regions– Key Companies
        13.1.3 Market Share by Countries– Key Companies
        13.1.4 Best Practices for Companies
14. Meningococcal Vaccines Market – Key Company List by Country Premium Premium
15. Meningococcal Vaccines Market Company Analysis
    15.1 Company 1
    15.2 Company 2
    15.3 Company 3
    15.4 Company 4
    15.5 Company 5
    15.6 Company 6
    15.7 Company 7
    15.8 Company 8
    15.9 Company 9
    15.10 Company 10
"*Financials for private companies would be provided on a best efforts basis”.

LIST OF TABLES

1.Global Competition Landscape Market 2023-2030 ($M)
2.Global Meningococcal Vaccines Market Analysis and Forecast , By Product Type Market 2023-2030 ($M)
2.1 Polysaccharide Meningococcal Vaccines Market 2023-2030 ($M) - Global Industry Research
2.2 Conjugate Meningococcal Vaccines Market 2023-2030 ($M) - Global Industry Research
2.3 By Product Type, Market 2023-2030 ($M) - Global Industry Research
3.Global Meningococcal Vaccines Market Analysis and Forecast , By Age Group Market 2023-2030 ($M)
3.1 Infants Market 2023-2030 ($M) - Global Industry Research
3.2 Children Market 2023-2030 ($M) - Global Industry Research
3.3 Adolescents young Adults Market 2023-2030 ($M) - Global Industry Research
3.4 Adults Market 2023-2030 ($M) - Global Industry Research
3.5 By Age Group, Market 2023-2030 ($M) - Global Industry Research
4.Global Meningococcal Vaccines Market Analysis and Forecast , By Distribution Channels Market 2023-2030 ($M)
4.1 Community Clinics Market 2023-2030 ($M) - Global Industry Research
4.2 Pharmacies Market 2023-2030 ($M) - Global Industry Research
4.3 Public Health Agencies Market 2023-2030 ($M) - Global Industry Research
5.Global Competition Landscape Market 2023-2030 (Volume/Units)
6.Global Meningococcal Vaccines Market Analysis and Forecast , By Product Type Market 2023-2030 (Volume/Units)
6.1 Polysaccharide Meningococcal Vaccines Market 2023-2030 (Volume/Units) - Global Industry Research
6.2 Conjugate Meningococcal Vaccines Market 2023-2030 (Volume/Units) - Global Industry Research
6.3 By Product Type, Market 2023-2030 (Volume/Units) - Global Industry Research
7.Global Meningococcal Vaccines Market Analysis and Forecast , By Age Group Market 2023-2030 (Volume/Units)
7.1 Infants Market 2023-2030 (Volume/Units) - Global Industry Research
7.2 Children Market 2023-2030 (Volume/Units) - Global Industry Research
7.3 Adolescents young Adults Market 2023-2030 (Volume/Units) - Global Industry Research
7.4 Adults Market 2023-2030 (Volume/Units) - Global Industry Research
7.5 By Age Group, Market 2023-2030 (Volume/Units) - Global Industry Research
8.Global Meningococcal Vaccines Market Analysis and Forecast , By Distribution Channels Market 2023-2030 (Volume/Units)
8.1 Community Clinics Market 2023-2030 (Volume/Units) - Global Industry Research
8.2 Pharmacies Market 2023-2030 (Volume/Units) - Global Industry Research
8.3 Public Health Agencies Market 2023-2030 (Volume/Units) - Global Industry Research
9.North America Competition Landscape Market 2023-2030 ($M)
10.North America Meningococcal Vaccines Market Analysis and Forecast , By Product Type Market 2023-2030 ($M)
10.1 Polysaccharide Meningococcal Vaccines Market 2023-2030 ($M) - Regional Industry Research
10.2 Conjugate Meningococcal Vaccines Market 2023-2030 ($M) - Regional Industry Research
10.3 By Product Type, Market 2023-2030 ($M) - Regional Industry Research
11.North America Meningococcal Vaccines Market Analysis and Forecast , By Age Group Market 2023-2030 ($M)
11.1 Infants Market 2023-2030 ($M) - Regional Industry Research
11.2 Children Market 2023-2030 ($M) - Regional Industry Research
11.3 Adolescents young Adults Market 2023-2030 ($M) - Regional Industry Research
11.4 Adults Market 2023-2030 ($M) - Regional Industry Research
11.5 By Age Group, Market 2023-2030 ($M) - Regional Industry Research
12.North America Meningococcal Vaccines Market Analysis and Forecast , By Distribution Channels Market 2023-2030 ($M)
12.1 Community Clinics Market 2023-2030 ($M) - Regional Industry Research
12.2 Pharmacies Market 2023-2030 ($M) - Regional Industry Research
12.3 Public Health Agencies Market 2023-2030 ($M) - Regional Industry Research
13.South America Competition Landscape Market 2023-2030 ($M)
14.South America Meningococcal Vaccines Market Analysis and Forecast , By Product Type Market 2023-2030 ($M)
14.1 Polysaccharide Meningococcal Vaccines Market 2023-2030 ($M) - Regional Industry Research
14.2 Conjugate Meningococcal Vaccines Market 2023-2030 ($M) - Regional Industry Research
14.3 By Product Type, Market 2023-2030 ($M) - Regional Industry Research
15.South America Meningococcal Vaccines Market Analysis and Forecast , By Age Group Market 2023-2030 ($M)
15.1 Infants Market 2023-2030 ($M) - Regional Industry Research
15.2 Children Market 2023-2030 ($M) - Regional Industry Research
15.3 Adolescents young Adults Market 2023-2030 ($M) - Regional Industry Research
15.4 Adults Market 2023-2030 ($M) - Regional Industry Research
15.5 By Age Group, Market 2023-2030 ($M) - Regional Industry Research
16.South America Meningococcal Vaccines Market Analysis and Forecast , By Distribution Channels Market 2023-2030 ($M)
16.1 Community Clinics Market 2023-2030 ($M) - Regional Industry Research
16.2 Pharmacies Market 2023-2030 ($M) - Regional Industry Research
16.3 Public Health Agencies Market 2023-2030 ($M) - Regional Industry Research
17.Europe Competition Landscape Market 2023-2030 ($M)
18.Europe Meningococcal Vaccines Market Analysis and Forecast , By Product Type Market 2023-2030 ($M)
18.1 Polysaccharide Meningococcal Vaccines Market 2023-2030 ($M) - Regional Industry Research
18.2 Conjugate Meningococcal Vaccines Market 2023-2030 ($M) - Regional Industry Research
18.3 By Product Type, Market 2023-2030 ($M) - Regional Industry Research
19.Europe Meningococcal Vaccines Market Analysis and Forecast , By Age Group Market 2023-2030 ($M)
19.1 Infants Market 2023-2030 ($M) - Regional Industry Research
19.2 Children Market 2023-2030 ($M) - Regional Industry Research
19.3 Adolescents young Adults Market 2023-2030 ($M) - Regional Industry Research
19.4 Adults Market 2023-2030 ($M) - Regional Industry Research
19.5 By Age Group, Market 2023-2030 ($M) - Regional Industry Research
20.Europe Meningococcal Vaccines Market Analysis and Forecast , By Distribution Channels Market 2023-2030 ($M)
20.1 Community Clinics Market 2023-2030 ($M) - Regional Industry Research
20.2 Pharmacies Market 2023-2030 ($M) - Regional Industry Research
20.3 Public Health Agencies Market 2023-2030 ($M) - Regional Industry Research
21.APAC Competition Landscape Market 2023-2030 ($M)
22.APAC Meningococcal Vaccines Market Analysis and Forecast , By Product Type Market 2023-2030 ($M)
22.1 Polysaccharide Meningococcal Vaccines Market 2023-2030 ($M) - Regional Industry Research
22.2 Conjugate Meningococcal Vaccines Market 2023-2030 ($M) - Regional Industry Research
22.3 By Product Type, Market 2023-2030 ($M) - Regional Industry Research
23.APAC Meningococcal Vaccines Market Analysis and Forecast , By Age Group Market 2023-2030 ($M)
23.1 Infants Market 2023-2030 ($M) - Regional Industry Research
23.2 Children Market 2023-2030 ($M) - Regional Industry Research
23.3 Adolescents young Adults Market 2023-2030 ($M) - Regional Industry Research
23.4 Adults Market 2023-2030 ($M) - Regional Industry Research
23.5 By Age Group, Market 2023-2030 ($M) - Regional Industry Research
24.APAC Meningococcal Vaccines Market Analysis and Forecast , By Distribution Channels Market 2023-2030 ($M)
24.1 Community Clinics Market 2023-2030 ($M) - Regional Industry Research
24.2 Pharmacies Market 2023-2030 ($M) - Regional Industry Research
24.3 Public Health Agencies Market 2023-2030 ($M) - Regional Industry Research
25.MENA Competition Landscape Market 2023-2030 ($M)
26.MENA Meningococcal Vaccines Market Analysis and Forecast , By Product Type Market 2023-2030 ($M)
26.1 Polysaccharide Meningococcal Vaccines Market 2023-2030 ($M) - Regional Industry Research
26.2 Conjugate Meningococcal Vaccines Market 2023-2030 ($M) - Regional Industry Research
26.3 By Product Type, Market 2023-2030 ($M) - Regional Industry Research
27.MENA Meningococcal Vaccines Market Analysis and Forecast , By Age Group Market 2023-2030 ($M)
27.1 Infants Market 2023-2030 ($M) - Regional Industry Research
27.2 Children Market 2023-2030 ($M) - Regional Industry Research
27.3 Adolescents young Adults Market 2023-2030 ($M) - Regional Industry Research
27.4 Adults Market 2023-2030 ($M) - Regional Industry Research
27.5 By Age Group, Market 2023-2030 ($M) - Regional Industry Research
28.MENA Meningococcal Vaccines Market Analysis and Forecast , By Distribution Channels Market 2023-2030 ($M)
28.1 Community Clinics Market 2023-2030 ($M) - Regional Industry Research
28.2 Pharmacies Market 2023-2030 ($M) - Regional Industry Research
28.3 Public Health Agencies Market 2023-2030 ($M) - Regional Industry Research

LIST OF FIGURES

1.US Meningococcal Vaccines Revenue In Asia Pacific 2019 Market Revenue, 2023-2030 ($M)
2.Canada Meningococcal Vaccines Revenue In Asia Pacific 2019 Market Revenue, 2023-2030 ($M)
3.Mexico Meningococcal Vaccines Revenue In Asia Pacific 2019 Market Revenue, 2023-2030 ($M)
4.Brazil Meningococcal Vaccines Revenue In Asia Pacific 2019 Market Revenue, 2023-2030 ($M)
5.Argentina Meningococcal Vaccines Revenue In Asia Pacific 2019 Market Revenue, 2023-2030 ($M)
6.Peru Meningococcal Vaccines Revenue In Asia Pacific 2019 Market Revenue, 2023-2030 ($M)
7.Colombia Meningococcal Vaccines Revenue In Asia Pacific 2019 Market Revenue, 2023-2030 ($M)
8.Chile Meningococcal Vaccines Revenue In Asia Pacific 2019 Market Revenue, 2023-2030 ($M)
9.Rest of South America Meningococcal Vaccines Revenue In Asia Pacific 2019 Market Revenue, 2023-2030 ($M)
10.UK Meningococcal Vaccines Revenue In Asia Pacific 2019 Market Revenue, 2023-2030 ($M)
11.Germany Meningococcal Vaccines Revenue In Asia Pacific 2019 Market Revenue, 2023-2030 ($M)
12.France Meningococcal Vaccines Revenue In Asia Pacific 2019 Market Revenue, 2023-2030 ($M)
13.Italy Meningococcal Vaccines Revenue In Asia Pacific 2019 Market Revenue, 2023-2030 ($M)
14.Spain Meningococcal Vaccines Revenue In Asia Pacific 2019 Market Revenue, 2023-2030 ($M)
15.Rest of Europe Meningococcal Vaccines Revenue In Asia Pacific 2019 Market Revenue, 2023-2030 ($M)
16.China Meningococcal Vaccines Revenue In Asia Pacific 2019 Market Revenue, 2023-2030 ($M)
17.India Meningococcal Vaccines Revenue In Asia Pacific 2019 Market Revenue, 2023-2030 ($M)
18.Japan Meningococcal Vaccines Revenue In Asia Pacific 2019 Market Revenue, 2023-2030 ($M)
19.South Korea Meningococcal Vaccines Revenue In Asia Pacific 2019 Market Revenue, 2023-2030 ($M)
20.South Africa Meningococcal Vaccines Revenue In Asia Pacific 2019 Market Revenue, 2023-2030 ($M)
21.North America Meningococcal Vaccines Revenue In Asia Pacific 2019 By Application
22.South America Meningococcal Vaccines Revenue In Asia Pacific 2019 By Application
23.Europe Meningococcal Vaccines Revenue In Asia Pacific 2019 By Application
24.APAC Meningococcal Vaccines Revenue In Asia Pacific 2019 By Application
25.MENA Meningococcal Vaccines Revenue In Asia Pacific 2019 By Application